Search alternatives:
significant effect » significant impact (Expand Search)
effect decrease » effects decreased (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), we decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
significant effect » significant impact (Expand Search)
effect decrease » effects decreased (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), we decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
21
-
22
-
23
Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).
Published 2025“…<p>Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).…”
-
24
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count.
Published 2025“…(B) Long-term-treatment with a low dose of netoglitazone also exhibits a patchy effect in decreasing plaque count. This effect is mainly observed in the olfactory, hindbrain, and visual areas. …”
-
25
-
26
-
27
-
28
-
29
Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0).
Published 2024Subjects: -
30
-
31
Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription.
Published 2024Subjects: -
32
-
33
-
34
-
35
Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease).
Published 2025“…<p>Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease).…”
-
36
Side effect.
Published 2025“…<div><p>Background</p><p>This study aimed to evaluate the clinical effectiveness of bilastine in type IIb autoimmune CSU (type IIb aiCSU) patients over an 8-week period, as well as to identify factors predicting treatment response.…”
-
37
-
38
-
39
-
40